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http:WHAT THIS PAPER ADDS
This study demonstrates that the presence of signiﬁcant angulation and calciﬁcation of the iliac arteries as well
as excessive limb oversizing appear to be independent predictors for endograft limb occlusion after endovas-
cular aortic repair. For the ﬁrst time the lack of clearly deﬁned predisposing factors for endograft limb
thrombosis led to the design of a case control study, which is ideal for studying multiple potential causes of a
disease.Objectives: The aim of this study was to investigate risk factors for endograft limb occlusion after endovascular
abdominal aneurysm repair (EVAR), using a case control design.
Methods: All patients presenting with endograft limb occlusion after elective EVAR between January 2010 and
June 2013, along with age, sex, and type of endograft matched controls were included in the study. The impact of
atherosclerotic risk factors, anatomic characteristics of the aneurysm, procedural details, and antiplatelet therapy
was investigated. Multivariate logistic regression analysis and conditional logistic regression analysis for 1:3
matched pairs deriving adjusted odds ratios (ORs) with 95% conﬁdence intervals (CIs) in order to detect
signiﬁcant risk factors for endograft limb occlusion among cases and controls were modeled.
Results: Of the 439 patients treated by EVAR, 18 patients (4.1%) presented with endograft limb occlusion. These
patients were compared to 54 matched controls. Limb occlusion was associated with iliac artery angulation 60
(OR ¼ 5.76, 95% CI ¼ 1.24e26.74; p ¼ .03) or perimeter calciﬁcation 50% (OR ¼ 5.87, 95% CI ¼ 1.10e31.32;
p ¼ .04). Limb occlusion was also associated with 15% endograft oversizing in the common iliac artery
(OR ¼ 5.54, 95% CI ¼ 1.11e27.60; p ¼ .04). No other risk factors for limb occlusion were recognized.
Conclusions: The presence of signiﬁcant angulation and calciﬁcation of the iliac arteries as well as excessive limb
oversizing appear to be independent predictors of endograft limb occlusion after EVAR.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Endovascular abdominal aneurysm repair (EVAR) has been
widely used for the treatment of patients with infrarenal
abdominal aortic aneurysms (AAAs). EVAR is considered to
have fewer short term complications than open recon-
struction of AAAs. However, long term durability of the
technique is probably limited by the high incidence of late
complications requiring re-intervention.1,2 A well known
risk after EVAR is endograft limb occlusion, especially in
complex iliac anatomy. It occurs in 2.6e7.4% of patients
during follow up24 and it usually requires intervention to
restore limb perfusion.2,3,5 Several anatomical risk factors
predisposing to limb thrombosis have been proposed,rresponding author. G.K. Mantas, Department of Vascular Surgery,
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//dx.doi.org/10.1016/j.ejvs.2014.09.012including common iliac artery diameter, calciﬁcation,
angulation, and the presence of thrombus, whereas pro-
cedure related risk factors for limb thrombosis include
endograft oversizing and extension to the external iliac ar-
tery.6e15 However, no study has yet compared these char-
acteristics between patients with endograft limb occlusion
and EVAR controls without limb occlusion.
The aim of this study was to present the experience with
endograft limb thrombosis in order to identify potential
anatomical and procedure related risk factors using a case
control design; each patient with endograft limb occlusion
was matched for sex, age, and commercial type of endog-
raft used to three patients having EVAR without limb
thrombosis.
MATERIALS AND METHODS
Patients
Between January 2010 and June 2013, 439 patients un-
derwent elective EVAR for AAA using bifurcated endografts.
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bifurcated endografts (n ¼ 439): Gore Excluder (n ¼ 139),
Cook Zenith (n ¼ 155), Vascutek Anaconda (n ¼ 111), and
Medtronic Endurant (n ¼ 34). All four types of these
commercially available endografts were used according to
their instructions for use, based on anatomical criteria and
the surgeon’s preference. A review of prospectively
collected data for all consecutive patients presenting with
endograft limb occlusion after elective EVAR for infrarenal
AAA repair was performed. Patients presenting with
ruptured or isolated iliac aneurysms or with a history of
previous aortic surgery were excluded. Each patient with
endograft limb occlusion (case) was matched for sex, age,
and commercial type of endograft used to three patients
having EVAR and no endograft limb occlusion (controls).
Cumulative random sampling of controls was carried out, in
which the controls were automatically matched on age
(within 3 years), gender, and type of endograft with cases in
the entire cohort of patients. In the next step, the ﬁxed
number (3) of control subjects for each case was randomly
selected. Increasing the number of controls above the
number of cases may be a cost effective way of improving
the study. The number of controls for each case was
increased to three in order to improve the chance of
detecting important differences.16 For this research,
approval of the Ethical Committee of the institution was
obtained and informed consent from each recruited patient
was mandatory.Surgical approach and technique
All procedures were performed in the operating theater
using a C-arm with angiographic and road mapping capa-
bilities (Philips BV Pulsera). Patients were administered
general or epidural anesthesia based on their comorbidities,
and access to the femoral arteries was obtained by surgical
dissection. Peri-operative antibiotic prophylaxis with intra-
venous vancomycin (1 g) and piperacillin plus tazobactam
(4.5 g) was administered 1 h before and 12 h after the
operation. Systemic heparinization was achieved with 5000
IU of heparin. All endovascular grafts were deployed below
the renal arteries, whereas endograft limbs were deployed
with a distal sealing zone in the common or external iliac
artery, depending on the extent of the aneurysm. Balloon
dilatation of the entire length of the endograft, and
completion angiography assessing graft position and func-
tion was performed routinely without stiff wires in place in
order to detect limb kinking that might predispose to
thrombosis. At discharge, antiplatelet medication was pre-
scribed to all patients. The follow up protocol included
history, physical examination and 1 mm slice computed
tomographic angiography (CTA) scan with intravenous
contrast at 30 days and 12 months post procedure and color
duplex ultrasound yearly thereafter. In cases with an
endoleak or hostile neck, CTA was also performed 6 months
post-operatively. On clinical suspicion of endograft limb
thrombosis, the diagnosis was conﬁrmed by CTA. Morpho-
logic analysis and measurement of aneurysm characteristicsbased on CTA scan were performed pre-operatively using
commercially available image processing software with
center lumen line reconstruction (Osirix MD, v.3.8.1 32 bit).
Commonly used cut off values for the variable of interest
were implemented.17 Angulation of the iliac artery was
estimated from the maximum iliac angulation measured
from the Osirix MD software centerline taking into account
the entire length between the aortic and the iliac bifurca-
tion. In addition, calciﬁcation of the iliac artery was classi-
ﬁed as distributed around more or less than 50% of the
circumference of the vessel. With respect to the oversizing,
the diameter at the end of the graft limb (seal zone diam-
eter) was used. Two independent observers (G.M., C.A.)
performed all image analyses, blinded to patient data and
inter observer agreement was determined using the
k statistic.
Variables of interest: exclusion criteria
Pre-operative factors extracted from patients’ medical re-
cords included age, gender, commercial endograft type
(Gore Excluder, Cook Zenith, Vascutek Anaconda, Med-
tronic Endurant), atherosclerotic risk factors (coronary ar-
tery disease; CAD, hyperlipidemia, hypertension, diabetes
mellitus; DM, smoking), antiplatelet therapy at discharge
(single, dual or other), pre-operative maximum aneurysm
diameter (cm), vascular access during EVAR indicating the
side used to deliver the main body of bifurcated prostheses
(right, left), pre-operative neck characteristics (length; cm,
diameter; cm, angle  45, calciﬁcation  50% of the
circumference, presence of luminal thrombus  50%) and
pre-operative characteristics of common iliac artery, ipsi-
lateral to endograft limb occlusion (diameter; cm, length;
cm, angle  60, calciﬁcation  50%, endograft limb
oversizing  15%, extension to the external iliac artery).
Post-operative follow up time was also considered as a
potential confounder and an additional multivariate anal-
ysis was also performed.
Statistical analysis
Continuous data were reported as mean  SD. Distribution
of categorical study characteristics was reported as per-
centage among cases and controls. Standard statistical
procedures (non-parametric chi-square distribution and
Student’s t-test with corresponding p values) were used to
assess differences in categorical and continuous study var-
iables among cases and controls, respectively. Univariate
logistic regression analysis was performed to derive crude
odds ratios (ORs) and 95% conﬁdence intervals (95% CIs) for
study variables among cases and controls from 2  2 tables.
Furthermore, multivariate logistic regression analysis and
conditional logistic regression analysis for 1:3 matched pairs
were modeled, to derive adjusted ORs with 95% CIs using
patients with endograft limb occlusion as cases and patients
with EVAR and patent endograft limbs as controls (depen-
dent variable) and signiﬁcant co-variates in univariate
analysis as predictor variables. All analyses were performed
using STATA version 11 (STATA Corp., TX, USA).
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A total of 18 patients (4%) with a mean age of 71.3  5.8
years presented with endograft limb occlusion. The occlu-
sion rate per commercially available endograft used was
2.2% (3/139) for Gore Excluder, 5.8% (9/155) for Cook
Zenith, 2.7% (3/111) for Vascutek Anaconda, and 8.8%
(3/34) for Medtronic Endurant. No statistical signiﬁcance for
occlusion rate was observed after all possible comparisons
among the different types of endografts (all p > .05). The 18
patients with endograft limb occlusion and 54 age, sex, and
type of endograft matched controls were included in the
study. There was one case of limb occlusion during the ﬁrst
post-operative week, two cases of endograft limb occlusion
between the ﬁrst and the fourth post-operative week, while
in the remaining 15 cases (83%) limb occlusion occurred
after 2e34 months. Diagnosis was based on clinical exam-
ination and imaging ﬁndings from color duplex ultrasound
and CTA. Seven of the 18 patients (39%) with endograft
limb occlusion presented with symptoms of acute limb
ischemia and were treated as an emergency, whereas the
remaining 11 patients presented with symptoms of buttock
or leg claudication and were treated electively by femoraleTable 1. Distribution of 18 cases with endograft limb occlusion and 54
Categorical variables Cases (n ¼ 1
n
Males 18
Graft type
Gore Excluder 3
Cook Zenith 9
Vascutek Anaconda 3
Medtronic Endurant 3
Coronary artery disease 5
Hyperlipidemia 12
Hypertension 14
Diabetes mellitus 3
Smoking 7
Antiplatelet therapy
Single 13
Dual 2
Other 3
Right access 17
Pre-operative neck characteristics
Angle 45 3
Calciﬁcation  50% 1
Thrombus  50% 3
Characteristics of common iliac artery, ipsilateral to endograft limb o
Angle  60 9
Calciﬁcation  50% 8
Endograft limb oversizing  15% 15
Extension to external iliac artery 4
Continuous variables Mean
Age 71.33
Pre-operative maximum aneurysm diameter (cm) 5.54
Pre-operative neck characteristics
Length (cm) 2.42
Diameter (cm) 2.35
Characteristics of common iliac artery, ipsilateral to endograft limb o
Diameter (cm) 1.61
Length (cm) 5.47femoral bypass. Thrombectomy was attempted in all seven
patients who presented with acute limb occlusion. How-
ever, in three it was impossible to advance the catheter into
the thrombosed endograft limb so they were treated by
femoralefemoral bypass. As a result, in 14 cases (78%) limb
reperfusion was achieved with a femoralefemoral bypass.
In the remaining four patients, limb thrombectomy and
stenting with balloon angioplasty was successful. Lower
limb perfusion was restored in all cases. During the 2e30
month follow up period after re-operation, one patient died
from thoracic aortic aneurysm rupture, two patients with a
previous femoralefemoral bypass required re-intervention
with axillo-femoral bypass, and the rest remained free of
symptoms. Statistically signiﬁcant agreement was recorded
between the two independent observers (k ¼ 0.65, p < .01)
regarding the morphologic analysis and the pre-operative
AAA measurements.
Table 1 presents differences among cases and controls
with respect to the variables studied. No statistically sig-
niﬁcant differences were observed regarding demographic
characteristics (matched variables), atherosclerotic risk
factors, antiplatelet therapy, access side, pre-operativeage, sex and type of endograft matched controls by risk factors.
8) Controls (n ¼ 54) p
% n %
100.0 54 100.0 Matched variable
Matched variable
17 9 17
50 27 50
17 9 17
17 9 17
28 22 41 .41
67 28 52 .27
78 47 87 .45
17 10 18.5 .99
39 17 31.5 .56
.43
72 36 67
11 12 22
17 5 9
94 44 81.5 .27
17 9 17 .99
6 5 9 .99
17 21 39 .15
cclusion
50.0 8 15 .002
44.4 7 13 .004
83.3 26 48 .01
22.2 7 13 .45
SD Mean SD p
5.77 71.67 5.43 Matched variable
1.16 5.51 0.80 .89
1.46 2.41 1.04 .96
0.64 2.43 0.33 .49
cclusion
0.47 1.65 0.66 .80
1.05 5.63 1.30 .64
42 G.K. Mantas et al.maximum aneurysm diameter and pre-operative neck
characteristics. In only two patients (1 case and 1 control)
was there signiﬁcant thrombus in the common iliac arteries.
Statistically signiﬁcant differences were observed in the pre-
operative characteristics of the common iliac artery ipsi-
lateral to the occluded endograft limb, including angle 60
(50% vs. 14.8%; p ¼ .002), calciﬁcation 50% (44.4% vs.
13%; p ¼ .004) and endograft limb oversizing 15% (83.3%
vs. 48.1%; p ¼ .01), respectively. Common iliac artery
angulation was evident in the post-operative CTA, but not in
the intra-operative ﬁnal digital subtraction angiogram (DSA)
in one patient.
Results of univariate analysis for endograft limb occlusion
by study covariates are presented in Table 2. An angle 60
(OR ¼ 5.75, 95% CI ¼ 1.75e18.91; p ¼ 0.004),
calciﬁcation  50% (OR ¼ 5.37, 95% CI ¼ 1.58e18.24;
p ¼ .007) and endograft limb oversizing 15% (OR ¼ 5.38,
95% CI ¼ 1.39e20.76; p ¼ .01) of the ipsilateral common
iliac artery increased the risk for endograft limb occlusion.
The signiﬁcance of the ﬁndings remained robust in the
conditional (matched pair case control) regression analysis
(Table 3). More speciﬁcally, endograft limb occlusion was
associated with angle 60 (OR ¼ 5.76, 95% CI ¼ 1.24e
26.74; p ¼ .03), calciﬁcation  50% (OR ¼ 5.87, 95%
CI ¼ 1.10e31.32; p ¼ .04) and endograft limb
oversizing  15% (OR ¼ 5.54, 95% CI ¼ 1.11e27.60;
p ¼ .04) of the common iliac artery, ipsilateral to endograft
limb occlusion. Time since operation did not prove to be a
signiﬁcant covariate (OR ¼ 1.04, 95% CI ¼ 0.96e1.09).DISCUSSION
A case control design has been used for the ﬁrst time to
investigate AAA characteristics which can be easily detectedTable 2. Univariate logistic regression derived ORs and 95% CIs for en
Variable Category o
Access Right vs. Le
Coronary artery disease Yes vs. No
Hyperlipidemia Yes vs. No
Hypertension Yes vs. No
Diabetes mellitus Yes vs. No
Smoking Yes vs. No
Antiplatelet therapy 1 Level mo
Pre-operative maximum aneurysm diameter (cm) 1 SD amon
Pre-operative neck characteristics
Angle 45 vs. <
Calciﬁcation 50% vs. <
Thrombus 50% vs. <
Length (cm) 1 SD amon
Diameter (cm) 1 SD amon
Characteristics of common iliac artery, ipsilateral to endograft limb o
Diameter (cm) 1 SD amon
Angle >60 vs. <
Calciﬁcation 50% vs. <
Length (cm) 1 SD amon
Endograft limb oversizing 15% vs. <
Extension to external iliac artery Yes vs. Noin the pre-operative CTA and which may predispose to post-
operative endograft limb occlusion. The results suggest that
angle 60, calciﬁcation 50% and endograft limb over-
sizing 15% of the ipsilateral common iliac artery may
present a more than ﬁvefold increase in risk for endograft
limb occlusion. In contrast, extension of the endograft into
the external iliac artery did not prove to be a signiﬁcant
factor. This is not in line with some of the previous studies,
identifying endograft extension to the external iliac artery
as a risk factor for limb thrombosis.18,19 The study by Wyss
et al.6 found that increased neck thrombus and common
iliac calciﬁcation appear to protect against complications. It
is possible that softer thrombus acts as a plaster like texture
resulting in a more snug apposition of the stent graft to the
vessel wall, whereas uneven calciﬁcations may impede close
apposition. However, quality of thrombus was not
measured in either Wyss et al.’s study or the current study,
and, as a result, ﬁndings may not be comparable. All the
other factors investigated in the study, including medical
history, pre-operative maximum aneurysm diameter (cm),
pre-operative neck characteristics, access site, and anti-
platelet therapy did not seem to have any impact on
endograft limb thrombosis.
The anatomic characteristics of the aorta and iliac ar-
teries must be carefully assessed when planning EVAR. The
aortic bifurcation must accommodate both limbs of the
endograft. Mural thrombus or atherosclerotic disease can
cause a narrow distal aortic lumen.7,15 EVAR in patients
with common iliac artery anatomy outside the instructions
for use (IFU) may be an important risk factor for endograft
limb compression and/or kinking and thrombosis. Among
these characteristics, severe iliac artery angulation and/or
tortuosity have been linked with early kink development.
Kinking of the endograft limb may not be visualized whendograft limb occlusion controlling by study covariates.
r increment Univariate logistic regression analysis
OR (95%CI) p
ft 0.26 (0.31e2.18) .21
0.56 (0.17e1.79) .33
1.86 (0.61e5.67) .28
0.52 (0.13e2.04) .35
0.88 (0.21e3.63) .86
1.39 (0.46e4.20) .56
re 1.06 (0.49e2.30) .88
g controls 1.04 (0.57e1.90) .89
45 1.00 (0.24e4.18) .99
50% 0.58 (0.06e5.29) .63
50% 0.31 (0.08e1.21) .10
g controls 1.01 (0.64e1.61) .96
g controls 0.66 (0.20e2.17) .50
cclusion
g controls 0.88 (0.34e2.27) .80
60 5.75 (1.75e18.91) .004
50% 5.37 (1.58e18.24) .007
g controls 0.90 (0.58e1.40) .63
15% 5.38 (1.39e20.76) .01
1.91 (0.49e7.52) .35
Table 3. Multivariate logistic regression and conditional logistic regression derived (matched pair case control) ORs and 95% CIs for
endograft limb occlusion controlling for signiﬁcant study covariates.
Characteristics of common iliac artery,
ipsilateral to endograft limb occlusion
Category or increment Multivariate Matched pair case control
OR (95%CI) p OR (95%CI) p
Angle 60 vs. <60 6.38 (1.57e25.93) .01 5.76 (1.24e26.74) .03
Calciﬁcation 50% vs. <50% 4.53 (1.11e18.43) .04 5.87 (1.10e31.32) .04
Endograft limb oversizing 15% vs. <15% 6.89 (1.46e32.59) .02 5.54 (1.11e27.60) .04
Factors Predisposing to Endograft Limb Occlusion 43the completion angiography is performed with the stiff wire
in place. Therefore, it is recommended that the completion
angiogram should be performed without stiff wires pre-
sent.15 In this series, no severe limb kinking was recognized
on the ﬁnal angiogram.
Patients included in this study were treated using four
types of endograft. There was no statistically signiﬁcant
difference in the incidence of limb thrombosis between the
different types of endografts (p ¼ .20), but this may be
attributed to the small sample size. However, some char-
acteristics of the endograft may be associated with limb
thrombosis. The main graft related cause of limb occlusion
is lack of support within the structure of the endograft.
Limb occlusion in the Guidant Ancure graft had been
described several times.20 During the short term follow up,
an unsupported graft will require re-intervention because of
kinking 15 times more often than a supported one.3
Excessive iliac oversizing has been recognized as a predis-
posing factor for limb thrombosis in this study. Excessive
oversizing of the endograft may lead to infolding of the
endograft limb into the vessel lumen. This is also supported
by the fact that oversizing of an iliac limb by 4 mm led to a
12-fold increase in graft limb dysfunction.3
Limited experience and lack of long term follow up makes
decisions for the optimal treatment of endograft limb
thrombosis difﬁcult. Both surgical and endovascular options
are available. Surgical options include thrombectomy and
extra-anatomic bypass graft. There are however concerns
about the possibility of graft damage or dislodgment and
endoleak during thrombectomy. On the other hand, this
argument was not validated by a series in which no endo-
leak or graft dislodgement occurred despite using throm-
bectomy in modular graft designs.21 Earlier experience
tended towards extra-anatomic bypass, mainly femorale
femoral bypass.22,23 Endovascular options include throm-
bolysis and balloon angioplasty or stenting and recent re-
ports have encouraged an endovascular approach with or
without thrombolysis.3,24,25 The majority of patients pre-
senting with a delayed (more than 15 days) limb thrombosis
were treated with a femoralefemoral bypass. In four cases
of early occlusion, endograft limb thrombectomy was suc-
cessfully performed and thereafter a stent was placed to
correct the cause of thrombosis. During the follow up
period two patients with a previous femoralefemoral
bypass due to limb thrombosis required re-intervention and
were treated with an axillo-femoral bypass graft.
Among the strengths of a case control design is the
simultaneous exploration of multiple risk factors and its
power to investigate potential associations that are difﬁcult
to be identiﬁed in case series. Furthermore, the number ofcontrols was increased to three for each case in order to
improve the ability to ﬁnd important differences. Limita-
tions of the current study may include a small study sample,
however, the case control design allowed for robust ﬁnd-
ings. A non-statistically signiﬁcant difference in the inci-
dence of endograft limb occlusion was noted between the
different types of endografts. However, this could be due to
the small sample size. Furthermore, a difference in follow
up time, although not statistical signiﬁcant was recorded
between cases and controls. In addition, in the multivariate
analysis time was not controlled, and a signiﬁcant effect of
time was not recorded. As a result, the ﬁndings remained
robust. On the other hand, in order to fully take into
consideration the effect of time on the probability of limb
occlusion, future studies should incorporate a prospective
cohort design.
CONCLUSION
Endograft limb thrombosis occurred in 4% of the patients
who underwent EVAR. The presence of signiﬁcant angula-
tion and calciﬁcation of the iliac arteries, as well as exces-
sive endograft limb oversizing appear to be independent
predictors of endograft limb occlusion.
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